查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1632683

全球獸用狂犬病疫苗市場：市場規模、佔有率、趨勢分析（按應用和地區）、細分市場預測（2025-2030 年）

Rabies Veterinary Vaccines Market Size, Share & Trends Analysis Report By Application (Companion Animals, Livestock Animals, Wildlife Animals), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

獸醫狂犬病疫苗市場的成長與趨勢：

根據 Grand View Research 的新報告，到 2030 年全球獸用狂犬病疫苗市場規模預計將達到 11 億美元。

預計 2025 年至 2030 年期間市場複合年成長率為 5.9%。推動市場發展的關鍵因素包括人們對通用感染疾病的認知不斷提高、流浪動物疫苗接種率提高以及政府加大力度，力爭到 2030 年消滅狂犬病。推動動物狂犬病疫苗接種市場的主要因素之一是對牲畜疫苗的認知和教育。核准用於牲畜的疫苗很多，包括去活化病毒載體產品、改良病毒載體產品、肌肉注射產品、皮下注射產品、1-3年免疫期產品和最低免疫年齡產品等。定期的公眾教育、負責任的寵物飼養、定期的獸醫治療和疫苗接種以及持續的專業培訓是狂犬病預防和控制的重要組成部分。透過普及狂犬病感染途徑等知識，提高人們避免接觸野生動物、對食用的野生動物接種狂犬病疫苗的意識，對遏制野生動物感染的蔓延有很大幫助。此外，疫苗接種改善了牲畜的整體健康狀況，並降低了全因死亡率。

狂犬病是一種攻擊中樞神經系統的致命疾病，一旦出現臨床症狀就無法有效治療方法。據估計，全球用於防治犬狂犬病的花費為 860 萬美元，佔每年發生的約 6 萬例狂犬病死亡病例的 98%。過去 50 年來，美國為消滅動物和人類的狂犬病做出了巨大努力。由於大規模動物疫苗接種方法的發展和自由放養限制的實施，感染狗源狂犬病的動物數量已從每年多達 10,000 例減少。儘管做出了這些努力，狂犬病仍然對公眾健康構成重大威脅，仍然在美國野生動物保護區的浣熊、臭鼬和狐狸中流行。

在世界各地，新冠肺炎疫情正在擾亂基本衛生服務。倡導「同一個健康」策略的聯合狂犬病論壇於2020年成立，旨在加速實現這一目標。全球狂犬病策略的關鍵組成部分包括社區參與、改善人類狂犬病疫苗的取得機會以及擴大犬類的大規模疫苗接種。狂犬病消除策略的進展可以作為衡量服務不足人口獲得醫療保健公平性的指標，也可以作為「同一個健康」成功的早期指標。大規模犬類疫苗接種是全球消除狂犬病策略的核心，目標疫苗接種覆蓋率達到70%。大多數受影響的國家都遇到了犬隻疫苗分發困難、數量減少和進口延遲等問題。這是因為狗疫苗最初並不在必需物品清單之中。即使在尚比亞等擁有本地生產能力的國家，由於預算限制，也不可能生產狗用疫苗。

狂犬病透過唾液傳播，並透過被感染動物的咬傷傳播。狂犬病可以透過猴子、狗、蝙蝠傳播，偶爾也透過貓傳播。印尼98%的狂犬病病例都是由瘋狗咬傷引起的。根據美國國家醫學圖書館 2021 年 12 月發表的一篇論文，過去十年中，全球動物狂犬病病例數量略有增加。 2017 年至 2018 年，泰國開展了一項研究，旨在描述動物狂犬病的特徵，使用廣義加性模型評估每月狂犬病發病率與可理解因素之間的關係，並估計狂犬病傳播的地理風險區域。研究顯示，狗是泰國最常見的感染狂犬病的動物種類。大多數受感染的狗都是家養的、放養的且未接種疫苗的狗。狂犬病感染集中度最高的是東北地區，其次是中部和南部地區。短期來看，自6月以來發病數逐漸增加，2018年1月以來發病數明顯增加。這些狂犬病流行國家正在採取強力的措施，例如針對犬類的大規模疫苗接種計劃、針對野生動物誘餌的狂犬病疫苗接種宣傳活動以及強制對寵物進行狂犬病疫苗接種，預計將促進市場成長。

獸醫狂犬病疫苗市場報告重點

  • 由於多個國家強制實施寵物狂犬病疫苗接種制度、主要實施大規模犬類疫苗接種計劃以及犬類擁有收益佔有率大幅上升，預計伴同性動物領域將在 2024 年佔據最大的收入佔有率。
  • 由於已開發地區野生動物狂犬病疫苗接種宣傳活動的加強，預計預測期內野生動物部門的複合年成長率將達到 4%。
  • 預計北美在預測期內仍將保持領先地位。這是因為該地區的人均獸醫護理支出高且寵物擁有率高。美國幾乎每個州都要求寵物定期接種狂犬病疫苗，以期在不久的將來實現消滅狂犬病的目標。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第 3 章 獸醫狂犬病疫苗市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 獸醫狂犬病疫苗市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析
  • 法律規範
  • 定價分析
  • COVID-19影響分析

第 4 章 獸醫狂犬病疫苗市場：按應用進行的估計和趨勢分析

  • 細分儀表板
  • 獸醫狂犬病疫苗市場：按應用進行趨勢分析
  • 獸用狂犬病疫苗的應用前景
  • 市場規模預測及趨勢分析（2018-2030年）
  • 伴同性動物
  • 家畜
  • 野生動物

第 5 章 獸醫狂犬病疫苗市場：按分銷管道進行的估計和趨勢分析

  • 細分儀表板
  • 獸醫狂犬病疫苗市場：按通路的波動分析
  • 獸用狂犬病疫苗分銷通路前景
  • 市場規模預測及趨勢分析（2018-2030年）
  • 零售
  • 電子商務
  • 醫院/診所藥房

第 6 章：獸用狂犬病疫苗市場：按地區分類的估計和趨勢分析

  • 區域控制面板
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 其他中東和非洲地區

第7章 競爭格局

  • 公司分類
  • 主要市場參與企業的最新趨勢和影響分析
  • 市場佔有率分析（按公司分類）（2024 年）
  • 公司概況
    • Boehringer Ingelheim International GmbH
    • Zoetis Services LLC
    • Indian Immunologicals Ltd.
    • Merck & Co., Inc.
    • Virbac
    • BiogenesisBago
    • Elanco
    • Ceva
    • BroadChem Philippines Biopharma Corporation
  • 戰略地圖
    • 企業合併與收購 (M&A)
    • 夥伴關係和合作
    • 擴張
    • 其他
  • 其他主要企業名單
Product Code: GVR-4-68040-011-9

Rabies Veterinary Vaccines Market Growth & Trends:

The global rabies veterinary vaccines market size is expected to reach USD 1.10 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.9% from 2025 to 2030. The key factors driving the market include an increase in zoonotic disease awareness, boosting stray animal immunization coverage, and growing number of government initiatives with the motive of eradicating rabies by 2030. One of the main drivers propelling the market for animal rabies vaccinations is domestic animal vaccine awareness and education. There are numerous vaccines approved for use in domestic animal species, which include inactivated and modified-live virus vector products, products for IM and SC injection, products with immunization durations ranging from 1 to 3 years, and products with a range of minimum vaccination ages. Regular public education, responsible pet ownership, routine veterinary treatment and vaccinations, and continuous professional training are crucial elements of rabies prevention and control. By spreading knowledge about rabies transmission channels, the necessity of avoiding contact with wildlife and vaccinating wildlife with bait rabies vaccines are widely initiated, which greatly helps in reducing the spread of the disease from wildlife sources. Additionally, the vaccination improves domestic animals' general health and is linked to a decline in all-cause mortality rates.

Rabies is a deadly disease that attacks the central nervous system and has no effective treatment once clinical signs appear. It is estimated that 8.6 million dollars are spent globally on canine rabies, which is responsible for 98% of approximately 60,000 total rabies deaths that occur each year. The U.S. has made enormous efforts over the past 50 years to eradicate rabies in both animal and human populations. The number of animals infected with canine-mediated rabies has decreased from up to 10,000 cases per year because of the development of mass animal vaccination procedures and the enforcement of leash restrictions. Despite these developments, rabies continues to pose a major threat to public health and is still prevalent in raccoons, skunks, and foxes in wildlife reservoirs throughout the U.S.

All around the world, the COVID-19 pandemic has disrupted crucial health services. The United Against Rabies Forum, which advocates a 'One Health' strategy, was established in 2020 to hasten the achievement of this objective. The main components of the global rabies strategy include community involvement, better access to human rabies vaccines, and expanded mass dog vaccination. The advancement of rabies eradication strategies can be used as a marker for the equity of healthcare access in underserved populations and as an early indicator for the successful implementation of 'One Health'. The core element of the global rabies elimination strategy is mass dog vaccination, with a 70% coverage rate as the goal. The majority of endemic nations saw difficulties with distribution, volume reductions, and importation delays for dog vaccines. This was because dog vaccines initially did not fit within the category of necessary items. Budget restrictions prevented the production of dog vaccines even in countries such as Zambia where they are made locally.

Rabies is spread through saliva, which means the infection can be transmitted through infected animal bites. Rabies can be transmitted by monkeys, dogs, bats, or, in some cases, cats. 98% of rabies cases in Indonesia are caused by rabid dog bites. According to an article published in December 2021, by the National Library of Medicine over the past 10 years, there has been a slight increase in the number of animal rabies cases globally. In Thailand, a study was conducted between 2017 and 2018 to identify the characteristics of animal rabies, assess the relationship between monthly rabies incidence and understandable factors using generalized additive models, and estimate the geographical risk areas for rabies spread. According to the study, dogs are the most common species in Thailand that are infected by rabies. The majority of the infected dogs were owned, roaming freely, and were not vaccinated. The northeast region of the country has the highest concentrations of rabies cases, followed by the middle and southern regions. In the short term, the number of cases increased gradually after June and significantly from January in 2018. Such rabies-endemic countries are taking strong measures such as dog mass vaccination programs, wildlife bait rabies vaccination campaigns, and mandatory pet rabies vaccinations among others, which are anticipated to fuel the growth of the market.

Rabies Veterinary Vaccines Market Report Highlights:

  • The companion animals segment held the largest revenue share in 2024 owing to the mandatory pet rabies vaccinations regulated in several countries, largely conducted mass dog vaccination programs, and significantly rising dog ownership rates
  • The wildlife animals segment is anticipated to expand at the fastest CAGR of 4% over the forecast period owing to the rising wildlife rabies vaccination campaigns in developed regions
  • North America is expected to maintain its lead over the forecast period. This is due to the region's high per capita animal healthcare spending and a large number of pet ownership rates. Almost every state in the U.S. mandates regular rabies vaccination for pets with the mission of eradicating rabies in the near future

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Vaccine Type
    • 1.2.3. Disease type
    • 1.2.4. Route of Administration
    • 1.2.5. Distribution Channel
    • 1.2.6. Regional Scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Rabies Veterinary VaccinesVariables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising animal rabies vaccination coverage in developing countries
      • 3.2.1.2. Increasing concerns over zoonotic diseases
      • 3.2.1.3. Implementation of mass dog vaccination campaigns in various countries
      • 3.2.1.4. Initiatives by market participants
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Limited access to veterinary services in under developed countries
  • 3.3. Rabies Veterinary VaccinesAnalysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
      • 3.3.2.7. Estimated Animal Population by key Species, key Country, 2018-2024
  • 3.4. Regulatory Framework
  • 3.5. Pricing Analysis
  • 3.6. COVID-19 impact Analysis

Chapter 4. Rabies Veterinary Vaccines market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Rabies Veterinary Vaccines market: Application Movement Analysis
  • 4.3. Rabies Veterinary Vaccinesby Application Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Companion Animals
    • 4.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.6. Livestock Animals
    • 4.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.7. Wildlife Animals
    • 4.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5. Rabies Veterinary Vaccines market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Rabies Veterinary Vaccines market: Distribution Channel Movement Analysis
  • 5.3. Rabies Veterinary Vaccinesby Distribution Channel Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Retail
    • 5.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6. E-Commerce
    • 5.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.7. Hospital/Clinic Pharmacies
    • 5.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6. Rabies Veterinary Vaccines market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. U.S. market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Canada market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Mexico market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. UK market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Germany market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. France market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Italy market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Spain market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Sweden market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Denmark market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Norway market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.4.9. Rest of Europe
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Rest of Europe market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Japan market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. China market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. India market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Australia market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. South Korea market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Thailand market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.5.7. Rest of Asia-Pacific
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Rest of Asia-Pacific market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Brazil market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Argentina market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.6.3. Rest of LA
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Rest of LA market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. South Africa market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. UAE market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Kuwait market estimates and forecasts 2018 to 2030, (USD Million)
    • 6.7.5. Rest of MEA
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Rest of MEA market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Recent Developments & Impact Analysis by Key Market Participants
  • 7.3. Company Market Share Analysis, 2024
  • 7.4. Company overview
    • 7.4.1. Boehringer Ingelheim International GmbH
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Zoetis Services LLC
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Indian Immunologicals Ltd.
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Merck & Co., Inc.
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Virbac
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. BiogenesisBago
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Elanco
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Ceva
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. BroadChem Philippines Biopharma Corporation
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
  • 7.5. Strategy Mapping
    • 7.5.1. Mergers & Acquisitions
    • 7.5.2. Partnerships & Collaborations
    • 7.5.3. Expansions
    • 7.5.4. Others
  • 7.6. List of Other Key Players

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 4. Global Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 5. Global Rabies Veterinary Vaccines market, by Region, 2018 - 2030 (USD Million)
  • Table 6. North America Rabies Veterinary Vaccines market, by Country, 2018 - 2030 (USD Million)
  • Table 7. North America Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 8. North America Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9. U.S. Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 10. U.S. Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11. Canada Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 12. Canada Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13. Mexico Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 14. Mexico Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15. Europe Rabies Veterinary Vaccines market, by Country, 2018 - 2030 (USD Million)
  • Table 16. Europe Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 17. Europe Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 18. UK Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 19. UK Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20. Germany Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 21. Germany Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 22. France Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 23. France Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24. Italy Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 25. Italy Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26. Spain Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 27. Spain Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 28. Sweden Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 29. Sweden Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30. Denmark Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 31. Denmark Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32. Norway Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 33. Norway Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34. Rest of Europe Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 35. Rest of Europe Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 37. Asia Pacific Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38. Japan Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 39. Japan Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 40. China Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 41. China Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42. India Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 43. India Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44. Australia Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 45. Australia Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46. South Korea Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 47. South Korea Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48. Thailand Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 49. Thailand Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50. Rest of Asia Pacific Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 51. Rest of Asia Pacific Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52. Latin America Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 53. Latin America Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54. Brazil Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 55. Brazil Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56. Argentina Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 57. Argentina Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58. Rest of LA Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 59. Rest of LA Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60. Middle East and Africa Rabies Veterinary Vaccines market, by Country, 2018 - 2030 (USD Million)
  • Table 61. Middle East and Africa Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 62. Middle East and Africa Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63. South Africa Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 64. South Africa Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 65. Saudi Arabia Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 66. Saudi Arabia Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67. UAE Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 68. UAE Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69. Kuwait Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 70. Kuwait Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 71. Rest of MEA Rabies Veterinary Vaccines market, By Application, 2018 - 2030 (USD Million)
  • Table 72. Rest of MEA Rabies Veterinary Vaccines market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Rabies Veterinary Vaccines market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Rabies Veterinary Vaccines market, for Application, 2018 - 2030 (USD Million)
  • Fig. 15 Global Rabies Veterinary Vaccines market, for Companion Animals, 2018 - 2030 (USD Million)
  • Fig. 16 Global Rabies Veterinary Vaccines market, for Livestock Animals, 2018 - 2030 (USD Million)
  • Fig. 17 Global Rabies Veterinary Vaccines market, for Wildlife Animals, 2018 - 2030 (USD Million)
  • Fig. 18 Global Rabies Veterinary Vaccines market, for Distribution Channel, 2018 - 2030 (USD Million)
  • Fig. 19 Global Rabies Veterinary Vaccines market, for Retail, 2018 - 2030 (USD Million)
  • Fig. 20 Global Rabies Veterinary Vaccines market, for E-Commerce, 2018 - 2030 (USD Million)
  • Fig. 21 Global Rabies Veterinary Vaccines market, for Hospital/Clinic Pharmacies, 2018 - 2030 (USD Million)
  • Fig. 22 Regional Outlook, 2024 & 2030
  • Fig. 23 North America Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 24 US Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 25 Canada Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 26 Mexico Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 27 Europe Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 28 UK Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 29 Germany Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 30 France Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 31 Italy Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 32 Spain Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 33 Sweden Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 34 Denmark Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 35 Norway Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 36 Rest of Europe Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 38 Japan Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 39 China Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 40 India Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 41 Australia Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 44 Rest of Asia Pacific Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 48 Rest of LA Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 52 UAE Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 54 Rest of MEA Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)